Advances in Interventional Cardiology: From Angioplasty to Valves on a Wire

Interventional cardiology is the treatment of the heart through catheters threaded along the blood vessels rather than through open surgery, and over fifty years it has grown from unblocking arteries into replacing whole valves inside a beating heart. This site exists because I was on the receiving end of that growth. A generation earlier, my failing valve would have meant the saw and the sternum or nothing; instead it meant a wire, an artery in my leg, and two nights in hospital. I wanted to understand the whole arc that made my two quiet nights possible, so this is the field, told from the outside in.

What interventional cardiology is

Interventional cardiology fixes the heart from the inside of its own plumbing. A thin catheter is threaded from a small puncture, usually in the groin or wrist, along the blood vessels to the heart, and devices are delivered down it, all on a beating heart with no chest incision and often only sedation ¹. The modern part of the field is called structural heart: not the arteries, but the heart’s physical structures, its valves, walls, and chambers.

It matters because the conditions it treats are common and serious. Aortic stenosis, the narrowed valve that this whole field learned to treat by catheter, affects roughly 2 to 4% of people over 75, and its prevalence climbs with age ². As populations age, the number of people who need a way to fix a heart without a major operation only grows.

From angioplasty to structural repair

The field advanced in clear stages, and knowing them makes the whole thing legible. It began in the late 1970s with balloon angioplasty, opening narrowed coronary arteries with an inflatable balloon, soon joined by stents that propped the arteries open. For years that was interventional cardiology: arteries, not structures.

The leap that created the modern era was structural: learning to deliver a whole heart valve by catheter, so a new valve could be expanded inside the diseased one. That idea was proven through the PARTNER and Evolut trial programmes, which extended transcatheter valves from inoperable patients out to high, then intermediate, then low surgical risk ³. A procedure once imaginable only for arteries became a way to replace valves, and the field’s centre of gravity shifted for good.

TAVR, the flagship advance

Transcatheter aortic valve replacement is the advance that defines the era, because it delivered on the structural promise for the commonest valve disease. Instead of removing the diseased aortic valve through the opened chest, TAVR expands a new valve inside the old one via the artery, cutting the hospital stay to about 1 to 3 days against the 5 to 7 of open surgery, with recovery in weeks rather than months ².

The stakes explain why this was worth achieving. Untreated severe symptomatic aortic stenosis carries a poor outlook, with survival often quoted at only around 50% at 2 years ¹. A less invasive way to treat it did not just add convenience; it made treatment possible for older and frailer people who had been turned away from surgery altogether. I have written the full explainer at what is TAVR for anyone who wants the procedure step by step.

Beyond the aortic valve

The catheter idea did not stop at the aortic valve, and that is what turned a single procedure into a field. The clearest example is the mitral valve, where a transcatheter edge-to-edge repair clips the leaking leaflets together for patients at high surgical risk, an approach carried directly from the aortic experience ⁴. I have explained it in MitraClip explained.

Interventional techniques now also close holes between the heart’s chambers and treat other structures, and the toolbox keeps widening. The aortic valve was the breakthrough that proved the principle; the mitral work showed the principle travels. The broad move from open surgery towards catheter procedures is set out in transcatheter versus surgical valve.

Why the advance matters, and its limits

The real value of these advances is choice, decided patient by patient rather than a wholesale replacement of surgery. Guidelines still favour surgery in younger, lower risk patients, largely because valve durability matters most when a person has decades ahead, and they favour the catheter route in older, higher risk ones ⁵. Neither has won; the point is that a heart team now has more than one good answer to offer.

That, in the end, is what happened to me. I was old enough and the risk was right, so the wire was the better answer, and a multidisciplinary team said so before anyone touched me ⁴. Interventional cardiology did not abolish the operation I feared. It gave me an alternative to it, and gave the doctors a genuine decision to make on my behalf. That widening of the possible is the advance, and it is why this site is called what it is.

General information, not medical advice. Which treatment, catheter or surgical, is right for you depends on your own heart, scans, age, and risks, and is a decision for your own heart team; please discuss your options with a qualified cardiologist and cardiac surgeon.